Overjet Secures $53 Million in Series C Funding to Revolutionize Dental Care with AI Technology

Overjet, a pioneering leader in dental artificial intelligence and a company founded by experts from MIT and Harvard University, has successfully raised $53 million in its latest funding round. This substantial investment highlights the confidence investors have in Overjet's innovative approach to transforming oral health care. Overjet's cutting-edge, FDA-cleared AI technology serves as the first objective standard in making oral health decisions, enabling dental organizations to detect pathologies with precision and provide patients with the highest quality of care. The funds raised will be instrumental in accelerating the expansion of Overjet's technology and refining its capabilities, ultimately aiming to further empower dental professionals to educate their patients with unmatched confidence. As the demand for advanced AI solutions in healthcare continues to rise, Overjet remains at the forefront, dedicated to enhancing clinical outcomes and streamlining workflows for dental practitioners. This new influx of capital not only solidifies Overjet's position as an industry leader but also opens avenues for broader implementation of its sophisticated AI tools, ensuring that more patients worldwide gain access to superior dental care. With this funding milestone, Overjet is well poised to continue its mission of revolutionizing dental practice, ensuring that both patients and dentists alike benefit from the precision and reliability that AI technology can offer in making informed oral health decisions.